Compare TOVX & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOVX | LUCY |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.7M |
| IPO Year | 2006 | 2022 |
| Metric | TOVX | LUCY |
|---|---|---|
| Price | $0.20 | $1.40 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 255.7K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,392,547.00 |
| Revenue This Year | N/A | $80.76 |
| Revenue Next Year | N/A | $210.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.22 |
| 52 Week Low | $0.17 | $1.29 |
| 52 Week High | $2.08 | $7.08 |
| Indicator | TOVX | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 41.46 |
| Support Level | $0.17 | $1.33 |
| Resistance Level | $0.24 | $1.43 |
| Average True Range (ATR) | 0.02 | 0.11 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 24.56 | 25.65 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.